Key result
Epoprostenol via Groshong catheters is linked to a ~5% rate of Micrococcus bloodstream infections.
Why the study?
Micrococcus is a common cause of bloodstream infection in patients with pulmonary hypertension on intravenous epoprostenol but is rarely reported in other patient groups.
Is continuous epoprostenol infusion via Groshong catheter associated with an increased risk of Micrococcus bloodstream infection in patients with pulmonary hypertension?
Observational (n=750)
No
Is continuous epoprostenol infusion via Groshong catheter associated with an increased risk of Micrococcus bloodstream infection in patients with pulmonary hypertension?
Micrococcus is a notable cause of bloodstream infections specifically in pulmonary hypertension patients receiving continuous intravenous epoprostenol via Groshong catheters.
Answers are grounded in this paper and cite their sources.
May warrant heightened monitoring for micrococcal BSI in PH patients on epoprostenol; hypothesis-generating and requires prospective confirmation.
Micrococcus is a common cause of bloodstream infection in patients with pulmonary hypertension (PH) on intravenous epoprostenol, but it is rarely reported in other groups of patients. We reviewed the blood cultures of all patients with PH on continuous epoprostenol infusion through a Groshong catheter treated at our institution from 2001 to 2006. Thirty-one (33%) of 93 patients with PH requiring epoprostenol infusion had a total of 45 bloodstream infections. Staphylococcus aureus and Staphylococcus epidermidis accounted for 21 (46%), followed by Micrococcus species with 5 cases (11%). No episodes of micrococcal bloodstream infection were identified in 657 patients without PH requiring Groshong catheters for other conditions during the same period. All isolates were susceptible to vancomycin, and in 1 case resistance to penicillin appeared 4 weeks after the treatment. No patient died as a consequence of the infection.
No takes yet. Share an insight, caveat, or question.
Valdivia-Arenas et al. (2008) conducted an observational in Pulmonary hypertension (n=750). Pulmonary hypertension on epoprostenol via Groshong catheter vs. Patients without pulmonary hypertension requiring Groshong catheters was evaluated on Micrococcal bloodstream infection. Micrococcal bloodstream infection occurred in 5.4% of pulmonary hypertension patients on epoprostenol via Groshong catheter, compared to 0% of patients with Groshong catheters for other conditions.
Synapse has enriched 10 related papers. Consider them for comparative context: